New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, describes the expansion of a novel program to train primary care physicians (PCPs) in the diagnosis and management of rheumatoid ...
Nov 7, 2023
0
0
For patients with acute coronary syndrome (ACS), stopping dual antiplatelet therapy (DAPT) within one month for ticagrelor monotherapy is noninferior and superior to 12 months of ticagrelor-based DAPT, according to a study ...
Oct 27, 2023
0
0
Use of low-dose aspirin (LDA) among pregnant women with inflammatory bowel disease (IBD) is not associated with an increased risk for disease activity, according to a study presented at the annual meeting of the American ...
Oct 27, 2023
0
0
As overdose deaths continue at a record pace, U.S. Customs and Border Protection announced a new government-wide strategy Thursday involving scores of agencies that will target the precursor materials used by traffickers ...
Oct 26, 2023
0
0
Gay and bisexual men at high risk for mpox infection should get vaccinated for the virus even after the current outbreak ends, government health advisers said Wednesday.
Oct 25, 2023
0
0
Breakthrough treatments introduced over the last decade have transformed hepatitis C from a chronic and potentially deadly infectious disease into one that can be cured. But these medications have often been beyond the reach ...
Oct 23, 2023
0
0
Tobacco retail licenses in New York City decreased by over 30 percent since 2018, when the City established a policy to cap the number of licenses in each of its 59 community districts, according to a study just released ...
Oct 18, 2023
0
0
Alexandra Touroutoglou, Ph.D., and Bradford Dickerson, MD, neuroscientists in the department of Neurology at Massachusetts General Hospital, are the lead authors of a new study published in Alzheimer's & Dementia, The Sporadic ...
Oct 18, 2023
0
0
Together with colleagues, veterinarian and neuroscientist Sonja Bröer has researched how regenerative cell therapies can contribute to curing or alleviating epilepsy. The work was carried out at biotechnology start-up Neurona ...
Oct 6, 2023
0
38
U.S. health officials plan to endorse a common antibiotic as a morning-after pill that gay and bisexual men can use to try to avoid some increasingly common sexually transmitted diseases.
Oct 2, 2023
0
1
